| Date | Form | Description | Docs | XBRL | Pages |
| 04/06/17 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 04/05/17 | 8-K | Current report filing |
|
4 | |
| 04/04/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/03/17 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/31/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
50 | |
| 03/27/17 | RW | Registration Withdrawal Request |
|
1 | |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 03/08/17 | 8-K | Current report filing |
|
34 | |
| 03/06/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
79 | |
| 02/14/17 | 8-K | Current report filing |
|
6 |
Latest News & Events
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...